Head-to-head · WeighScore
Clume Health vs Direct Meds
The verdict
Direct Meds takes it — 77.6/100 to 63.7/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Clume Health | Direct Meds |
|---|---|---|
| WeighScore | 63.7/100 | 77.6/100 |
| Grade | C | C+ |
| Site position | #279 | #35 |
| Semaglutide | $259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan) | $249/mo sublingual · $297/mo injectable |
| Tirzepatide | $259/mo (Signature full dose, oral or injectable; $186/mo requires a 52-week plan) | $299/mo sublingual · $399/mo injectable |
| Coverage | All 50 states plus Washington, D.C. | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #279 · C
Strengths
- One Signature price covers semaglutide or tirzepatide, injectable or oral, so switching molecule or route does not change the bill
- A separate microdose and maintenance program is priced on its own at $219 a month rather than sold as a discount on the main line
- Names four dispensing pharmacies with street addresses and phone numbers, which is more than most of the field publishes
- States service in all 50 states plus Washington, D.C. without contradicting itself elsewhere
- A full refund is available if the subscription is canceled within the first 72 hours and before the medication ships
Where it loses points
- Neither homepage hero price matches anything sold: $199 a month is advertised against real floors of $259 and $219, and $159 against a figure of $216 that itself needs a 12-week plan
- Both hero prices carry an asterisk that resolves to no footnote anywhere on the page
- The cheaper monthly figures are commitments — $186 needs 52 weeks and $200 needs 12 — printed on the same card as the month-to-month rate
- The refund policy promises a 24/7 patient support line and no phone number appears anywhere on the site; support is email only
- Whether the medication is compounded, and under 503A or 503B, is never stated
- No clinician is named. The Terms name only “the OpenLoop Medical Practices”, with no individual, no NPI and no medical group entity
Site position #35 · C+
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Strengths
- Rare oral/sublingual option in addition to injectable
- All-inclusive pricing with no separate membership fee
- Both molecules — semaglutide and tirzepatide
- Intro promotional pricing near $147
Where it loses points
- Compounded only — not FDA-approved
- Pricing is company-stated, not independently live-verified
- Newer and somewhat ambiguous (operates across multiple domains)
- States served are not disclosed
Featured provider
Direct Meds
Direct Meds scores 77.6/100 (C+). One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.